Lipoxin A4

Synonyms: 脂氧素 A4; LXA4
Lipoxin A4 (LXA4) 是一种内源性脂氧合酶衍生的类二十烷酸调节剂,兼具强大的抗炎和促消炎双重特性,可抑制与 ERK1/2 和 NF-kB 通路相关的人表皮角质形成细胞 (NHEK) 的增殖以及炎性细胞因子/趋化因子(如 IL-6、IL-8 等)的产生,并以 IC50 值 25.74 nM 抑制血清淀粉样蛋白 A (SAA) 介导的 IL-8 释放。
产品编号: MS-X34009 纯度: 98.0% CAS No.: 89663-86-5 分子式: C20H32O5 分子量: 352.47
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
25μg (283.71μM * 250μL in Ethanol)
询价
3-5 天

产品描述

Lipoxin A4 (LXA4) 是一种内源性脂氧合酶衍生的类二十烷酸调节剂,兼具强大的抗炎和促消炎双重特性,可抑制与 ERK1/2 和 NF-kB 通路相关的人表皮角质形成细胞 (NHEK) 的增殖以及炎性细胞因子/趋化因子(如 IL-6、IL-8 等)的产生,并以 IC50 值 25.74 nM 抑制血清淀粉样蛋白 A (SAA) 介导的 IL-8 释放。

生物实验数据

生物活性 Lipoxin A4 (LXA4) is an endogenous lipoxygenase-derived eicosanoid regulator with potent dual anti-inflammatory and pro-resolving properties that inhibits the proliferation of human epidermal keratinocytes (NHEK) and the production of inflammatory cytokines/chemokines (such as IL-6, IL-8, etc.) associated with the ERK1/2 and NF-kB pathways, and inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM.
IC50 & Target

IL-6

 

IL-8

 

Human Endogenous Metabolite

 

体外研究
(In Vitro)

LXA4 pretreatment (100 nM for 30 minutes) downregulates the LPS-induced secretion and expression of HMGB1 in keratinocytes.
Lipoxin A4 (LXA4) inhibits the expression of IL-6 and IL-8 in NHEKs.
Lipoxin A4 downregulates the expression of cyclin D1.
Lipoxin A4 also suppresses the ERK1/2 phosphorylation and NF-kB-p65 nuclear translocation of NHEKs.
LXA4 (100 nM; preincubation for 30 minutes)inhibits the proliferation of NHEKs with or without stimulating by LPS (10 μg/mL).

Western Blot Analysis

Cell Line: Normal human epidermal keratinocytes (NHEKs)
Concentration: 100 nM
Incubation Time: 30 minutes.
Result: HMGB1 protein levels in the cytoplasm of NHEKs were induced by LPS, which were decreased after preincubation with LXA4 but decreased in the nucleus after stimulation with LPS.

Cell Proliferation Assay

Cell Line: Normal human epidermal keratinocytes (NHEKs)
Concentration: 100 nM
Incubation Time: 30 minutes
Result: A significant increase in proliferation of NHEKs after 7 days of stimulation with LPS (10 μg/mL) was seen. However, there was a significant decrease in the proliferation of NHEKs when pretreated with LXA4 for 30 min.
体内研究
(In Vivo)

Lipoxin A4 (intrathecal injection; 10-100 ng; 3 days) potently alleviates radicular pain in a rat model of non-compressive lumbar disc herniation.

Animal Model: Rat models of non-compressive lumbar disc herniation
Dosage: 10 and 100 ng
Administration: Intrathecal injection; 3 days
Result: Alleviated the development of neuropathic pain.
Inhibited the upregulation of pro-inflammatory cytokines (TNF-a and IL-1β).
Upregulated the expression of anti-inflammatory cytokines (TGF-β1 and IL-10) and attenuated the activation of NF-κB/p65, p-ERK, p-JNK, but not p-p38.
性状 液体
颜色 Colorless to light yellow

化学信息

分子量 352.47
分子式 C20H32O5
CAS No. 89663-86-5
别名 脂氧素 A4; LXA4

储存&溶解度

溶解度信息
PBS (pH 7.2): 0.05 mg/mL (0.14 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble.)
Ethanol: 30 mg/mL (85.11 mM), Sonication is recommended.
储存方式

Solution, -20°C, 1 year

运输条件 Shipping with dry ice.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础